Restless Legs Syndrome :: Boehringer Ingelheim?s pramipexole for the treatment of Restless Legs Syndrome RLS

Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved pramipexole, a non-ergot dopamine agonist, for the treatment of moderate to severe primary Restless Legs Syndrome (RLS).1 This is an important milestone for pramipexole (Mirapexin? / Sifrol? / Mirapex?), which was already approved throughout the European Union in April 2006 for this second indication.

Glaucoma :: Study probes eye disease and falls

Volunteers for a study on the degenerative eye disease, glaucoma, and its link with falls in older people are being sought by a Queensland University of Technology optometry researcher.

Health :: Red wines’ resveratrol offers survival benefits, increases lifespan

Researchers have used a single compound to increase the lifespan of obese mice, and found that the drug reversed nearly all of the changes in gene expression patterns found in mice on high calorie diets–some of which are associated with diabetes, heart disease, and other significant diseases related to obesity. The research, led by investigators at Harvard Medical School and the National Institute on Aging, is the first time that the small molecule resveratrol has been shown to offer survival benefits in a mammal. The study is reported in the November 1 advanced online edition of Nature.

Plantar Fasciitis :: New stretch relieves pain from plantar fasciitis

A new stretch is proving quite effective to help treat and potentially cure plantar fasciitis, a condition that affects nearly 2.5 million Americans each year. In a study recently published in Journal of Bone and Joint Surgery, researchers found that patients suffering from the painful heel spur syndrome had a 75 percent chance of having no pain and returning to full activity within three to six months of performing the stretch. In addition, patients have about a 75 percent chance of needing no further treatment.

Parkinson’s Disease :: Patients face tough treatment ‘Balancing Act’

Last week, in one of TV ad Actor Michael J. Fox appeared with his disturbingly uncontrolled movements. And, his opponents in the stem-cell debate accused him of either acting or purposefully not taking his medications, in an effort to gain sympathy, quoted by news agencies worldwide. Nothing could be further from the truth, according to Parkinson’s experts. In fact, Fox’s disordered movement — a condition called dyskinesia — was mainly due to his taking medication to help control his Parkinson’s, they said.

Exercise :: Walking not enough for significant exercise benefits

Walking is a popular form of exercise, but may not be enough to experience significant health benefits, a University of Alberta study shows. “Generally, low-intensity activity such as walking alone is not likely going to give anybody marked health benefits compared to programs that occasionally elevate the intensity,” said Dr. Vicki Harber, lead author on the Health First study, which was presented recently at the American College of Sports Medicine annual conference.

Health :: Safe Kids Coalition offers Halloween safety tips

Dauphin County Safe Kids Coalition, led by Penn State Children’s Hospital, reminds parents this Halloween that Oct. 31 is the most dangerous day of the year for child pedestrians. In fact, children are four times more likely to be killed while walking on Halloween than any other night of the year. It is essential for parents to prepare their children properly to stay safe while having fun.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack